PCB-RiskNCT07549438
Predicting the Risk of Partial Ciliary Block After Cataract and Goniosynechialysis Surgery in Primary Angle-Closure Disease
StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 9 words
- Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Incidence of Ciliary Block (Classic and Partial)
Timeframe: Up to 12 months postoperatively
Arms and interventions
CB Group
Patients who develop classic or partial ciliary block (CB) during the 12-month follow-up period after phacoemulsification combined with goniosynechialysis.
Non-CB Group
Patients who do not develop any form of ciliary block during the 12-month follow-up period after the surgery.
Sites
1 site in 1 country
- Zhiqiao LiangBeijing, Beijing Municipality, China